Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study
- 1 February 2015
- journal article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 14 (2), 168-173
- https://doi.org/10.1016/j.autrev.2014.10.017
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in FranceBlood, 2014
- Pharmacoepidemiology of Immune Thrombocytopenia: Protocols of FAITH and CARMEN StudiesTherapies, 2014
- Diagnosis and classification of immune-mediated thrombocytopeniaAutoimmunity Reviews, 2014
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopeniaBlood, 2011
- French national health insurance information system and the permanent beneficiaries sampleRevue D'epidemiologie Et de Sante Publique, 2010
- The geoepidemiology of immune thrombocytopenic purpuraAutoimmunity Reviews, 2010
- International consensus report on the investigation and management of primary immune thrombocytopeniaBlood, 2010
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]Blood, 1996
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987